Pavan Sharma

Never miss an opportunity with high impact economic event coverage, expert commentary, videos and more from our global market analysts.

11 February 2021 -

Benign Inflation | Briscoes Sales Boost

Inflation data for January showed US core consumer prices were flat for a second consecutive month (and up 1.4% year on year), below expectations.

11 February 2021 -

Wall Street Takes a Breather | Macquarie Upgrade

Global markets were mixed overnight (S&P 500 index -0.1%) as investors took profits after a 6-day winning streak.

10 February 2021 -

Week Ahead | Finding Value in a Market at Highs

It is hard to find “value” when markets are at highs, but we see currently see value in QBE shares. Further, as we have discussed in the past, QBE is one of the only Australasian listed companies which benefits directly from higher US interest rates (as i

10 February 2021 -

Week Ahead | Finding Value in a Market at Highs – QBE

markets marched higher for 6th straight session (the longest rally since August) on virus infection rates slowdown & prospects of more stimulus.

6 February 2021 -

Fisher & Paykel Healthcare : FPH – NZX/ASX – Stunning Growth

’s initial recommendation on FPH was at $9.79 in 2016 which delivered a massive capital growth of 242.19% so far for our investors. The stock has been moving sideways and consolidating since September last year within the range of $37.00 to $31.00.

6 February 2021 -

Very Healthy Numbers

6 February 2021 -

Upgrade to HOLD (From SELL)

6 February 2021 -

Santa Sales Surge

6 February 2021 -

Rally Builds | Fletcher’s – Building Consents Boost

Fletcher Building (FBU) shares have been performing well recently as the property market boom continues.